semaglutide oral cardiovascular indication 2025 news in High-Risk Type 2 Diabetes: Benefit Confirmed in the SOUL Trial ACC 2025: Oral Semaglutide Reduces – Cardiovascular outcomes of semaglutide and

Vidotti, J

The pill demands strict daily consistency

This, in turn, may affect appetite." However, there was no link between changes in taste perception and reduction in BMI

The anti-inflammatory properties of GLP-1 receptor agonists could play a protective role, though researchers are still investigating the precise mechanisms

After injection, dispose of used needles safely in a sharps bin according to local arrangements

For most people: Nausea, bloating, or digestive issues improve within a few days to 12 weeks Appetite gradually returns Energy levels normalize If side effects continue beyond a couple of weeks after stopping, its a good idea to check in with a medical provider